Tower Research Capital LLC (Trc) Celcuity Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Celcuity Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 531 shares of CELC stock, worth $5,044. This represents 0.0% of its overall portfolio holdings.
Number of Shares
531
Previous 1,680
68.39%
Holding current value
$5,044
Previous $25,000
76.0%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding CELC
# of Institutions
104Shares Held
30MCall Options Held
17.5KPut Options Held
100-
Bvf Inc San Francisco, CA3.47MShares$32.9 Million1.7% of portfolio
-
Baker Bros. Advisors LP New York, NY2.68MShares$25.4 Million0.39% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.57MShares$24.4 Million2.34% of portfolio
-
Perceptive Advisors LLC New York, NY2.36MShares$22.4 Million1.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.65MShares$15.7 Million0.0% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $142M
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...